Skip to main content
Last Updated
Case Status
In the Matter of AbbVie Inc., a corporation; and Allergan plc, a public limited company.
FTC Matter/File Number
191 0169
Enforcement Type
Part 2 Consents

Case Summary

Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent agreement in this matter.